Evogene Ltd. (NYSE:EVGN) on 8 April announced that it has filed its annual report containing audited consolidated financial statements for the year ended December 31, 2013 with the United States Securities and Exchange Commission, on Form 20-F. Evogene Ltd (NYSE:EVGN) shares after opening at $19.16 moved to $19.21 on last trade day and at the end of the day closed at $18.20. Company price to sales ratio in past twelve months was calculated as 25.78. Evogene Ltd (NYSE:EVGN) showed a negative weekly performance of -5.45%.
On March 20, 2014, Ambit Biosciences Corp (NASDAQ:AMBI) announced financial results for the quarter and year ended December 31, 2013. Ambit Biosciences Corp (NASDAQ:AMBI) shares fell -6.86% in last trading session and ended the day on $8.15. AMBI return on equity ratio is recorded as 176.90% and its return on assets is -20.50%.
CAS Medical Systems Inc. (NASDAQ:CASM) net loss for 2013 was $10,362,000, or ($0.66) per basic and diluted common share, compared to a net loss for 2012 of $7,308,000, or ($0.55) per basic and diluted common share. CAS Medical Systems Inc. (NASDAQ:CASM) shares moved up 0.48% in last trading session and was closed at $2.11, while trading in range of $2.10 – $2.17. CAS Medical Systems Inc. (NASDAQ:CASM) year to date (YTD) performance is 24.12%.
SIGA Technologies, Inc. (NASDAQ:SIGA) Net cash provided by operations for the year ended December 31, 2013 was $58.4 million; net cash used in operations for the year ended December 31, 2012 was $20.2 million and net cash provided by operations during the year ended December 31, 2011 was $25.6 million. SIGA Technologies, Inc. (NASDAQ:SIGA) weekly performance is -1.96%. On last trading day company shares ended up $3.00. SIGA Technologies, Inc. (NASDAQ:SIGA) distance from 50-day simple moving average (SMA50) is -6.33%. Analysts mean target price for the company is $11.00.